Hormonal Birth Control

Double dosing UPA for EC not needed for BMI > 30, postpartum implant placement and milk supply, mifepristone to increase efficacy of medication management of EPL.

New and updated guidance on the initiation and management of contraception, including pain management options for IUD placement, support for DMPA-SQ, and new conditions and methods added.

Intrauterine mepivacaine for IUD placement, the impact of abortion restrictions on medical training, pregnancy of unknown location and very early medication abortion, and navigating abortion misinformation

LNG-IUD and the risk of gynecologic and breast cancers, contraception and body weight, and preferred ways to get hormonal birth control.

Factors that increase risk for deep or nonpalpable implant, 12-hour vs. 24-hour mifepristone-misoprostol interval, and two studies reinforcing the safety and efficacy of no-test medication abortion.

Answers for health care providers about prescribing extended contraception supplies.

A patient-centered decision aid for tubal sterilization counseling, IUD self-removal experiences, and counseling about pain and medication abortion.

Answers for health care providers about birth control options after abortion